68Ga-DOTA-RBB

N/A

Report date: 2025/10/23 16:05:43

Base Information

Drug Name68Ga-DOTA-RBB

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors

TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 6

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesThe First Affiliated Hospital Of Anhui Medical University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Anhui Medical University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A